• Science News: Lithium, Antidepressants, Esketamine—All No Better Than Placebo?

  • Feb 10 2022
  • Length: 32 mins
  • Podcast

Science News: Lithium, Antidepressants, Esketamine—All No Better Than Placebo?

  • Summary

  • Peter Simons covers a clinical trial that found lithium ineffective at preventing suicide attempts, an essay by Allen Frances on the overdiagnosis of depression and overprescription of antidepressants, a review of the ineffectiveness and dangers of antidepressants, and an analysis that revealed that esketamine failed five of its six clinical trials.
    • Lithium No Better Than Placebo for Preventing Suicide Attempts
    • New Review: Antidepressants Come with Minimal Benefits, Several Risks
    • Allen Frances Takes on the Over-Prescription of Antidepressants
    • Esketamine Failed in Five of its Six Efficacy Trials
    • Ketamine Withdrawal Has Severe Consequences
    • New Study of Ayahuasca Users Shows Placebo Effect in Action

     

    Show More Show Less

What listeners say about Science News: Lithium, Antidepressants, Esketamine—All No Better Than Placebo?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.